Abstract
Lower urinary tract symptoms are common in the male population over 50 years of age. While in the majority of patients there are no sinister underlying abnormalities, it is important that men are educated to present for investigation and management at an early stage. Shared care between hospital services and primary care has resulted in significant improvements in patient care over the last 10 years. Clarification about the terminology used and the risk factors for progression has led to more appropriate targeting of treatment to those men who will benefit most. Further research into the natural history of benign prostate and bladder conditions will yield further improvements.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Garraway WM, Collins GN, Lee RJ. High prevalence of benign prostatic hypertrophy in the community. Lancet 1991; 338: 469–71.
Speakman MJ. Lower urinary tract symptoms suggestive of benign prostatic obstruction: what is the available evidence for rational management? Eur Urol 2001; 39 S3: 6–12.
Sells H, Donovan J, Ewings P, et al. The development and validation of a quality-of-life measure to assess partner morbidity in benign prostatic enlargement. BJU Int 2000 Mar; 85 (4): 440–5.
Abrams PH. Prostatism and prostatectomy: the value of urine flow rate measurement in the preoperative assessment for operation. J Urol 1977; 117 (1): 70–1.
Abrams PH, Farrar DJ, Turner-Warwick RT, et al. The results of prostatectomy: a symptomatic and urodynamic analysis of 152 patients. JUrol 1979 May; 121 (5): 640–2.
Brookes ST, Donovan JL, Peters TJ, et al. Sexual dysfunction in men after treatment for lower urinary tract symptoms: evidence from a randomised controlled trial. BMJ 2002 May 4; 324 (7345): 1059–61.
Hirst GH, Ward JE. Clinical practice guidelines: reality bites. Med J Aust 2000; 172 (6): 287–91.
Morris SB, Pogson C, Shearer RJ. Shared care for benign prostatic hyperplasia: a feasibility study. Br J Urol 1995 Jul; 76 (1): 77–80.
Booth CM, Chaudry AA, Smith K, et al. The benefits of a shared-care prostate clinic. Br J Urol 1996 Jun; 77 (6): 830–5.
Pillinger JET. Setting up a shared care urology clinic. Trends Urol Gynaecol Sexual Health 2002 May 1; 25–30.
Kirby RS, Chisholm G, Chappie C, et al. Shared care between general practitioners and urologists in the management of benign prostatic hyperplasia: a survey of attitudes among clinicians. J R Soc Med 1995 May; 88(5): 284P–8P.
Lycklama A, Nijeholt AA. Benign prostate hyperplasia; shared care reduces care load. Ned Tijdschr Geneeskd 1998 Nov 21; 142 (47): 2556–7.
Talseth T, Hedlund H. Benign prostatic hyperplasia: shared care between urologists and general practitioners. Tidsskr Nor Laegeforen 1997 Jan 30; 117 (3): 389–93.
Padilla Leon M, Marchai Escalona C, Alcantara J, et al. Shared care in BPH: first national experience. Actas Urol Esp 1998 Jun; 22 (6): 478–83.
de la Rosette JJ, van der Schoot DK, Debruyne FM. Recent developments in guidelines on benign prostatic hyperplasia. Curr Opin Urol 2002 Jan; 12 (1): 3–6.
Speakman MJ, Kirk D, Gingell C, et al. Shared care of BPH — a general practice based study [abstract]. J Urol 1996; 155 (5): 391.
Plante M, Corcos J, Gregoire I, et al. The International Prostate Symptom Score: physician versus self administration. Urology 1996; 47 (3): 326–8.
MacDonagh RP, Cliff AM, Speakman MJ, et al. The use of generic measures of health-related quality of life in the assessment of outcome from transurethral resection of the prostate. Br J Urol 1997 Mar; 79 (3): 401–8.
Speakman MJ. Initial choices and final outcomes in lower urinary tract symptoms. Eur Urol 2001; 40 Suppl. 4: 21–30.
Treagust J, Morkane T, Speakman M. Estimating a population’s needs for the treatment of lower urinary tract symptoms in men: what is the extent of unmet need? J Public Health Med 2001 Jun; 23(2): 141–7.
Jacobsen SJ, Jacobsen DJ, Girman CJ, et al. Natural history of prostatism: risk factors for acute urinary retention. J Urol 1997 Aug; 158 (2): 481–7.
McConnell JD, Bruskewitz R, Walsh P, et al. The effect of finasteride on the risk of acute urinary retention and the need for surgical treatment among men with benign prostatic hyperplasia. Finasteride Long-Term Efficacy and Safety Study Group. N Engl J Med 1998 Feb 26; 338 (9): 557–63.
Roehrborn CG, Malice M, Cook TJ, et al. Clinical predictors of spontaneous acute urinary retention in men with LUTS and clinical BPH: a comprehensive analysis of the pooled placebo groups of several large clinical trials. Urology 2001 Aug; 58 (2): 210–6.
Manyak MJ, Ackerman SJ, Blute ML, et al. Cost effectiveness of treatment for benign prostatic hyperplasia: an economic model for comparison of medical, minimally invasive, and surgical therapy. J Endourol 2002; 16 (1): 51–6.
McDonnell J, Busschbach JJ, Kok E, et al. Lower urinary tract symptoms suggestive of benign prostatic obstruction: triumph: health-economical analysis. Eur Urol 2001; 39 Suppl. 3:37–41.
Acknowledgements
The authors have no sources of funding or conflicts of interest that are directly relevant to the content of this review.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Speakman, M.J. Disease Management Programs to Promote Early Diagnosis and Treatment of Benign Prostatic Hyperplasia. Dis-Manage-Health-Outcomes 11, 7–10 (2003). https://doi.org/10.2165/00115677-200311010-00002
Published:
Issue Date:
DOI: https://doi.org/10.2165/00115677-200311010-00002